FSCN-1 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial-mesenchymal transition

Resistance to chemotherapy drugs remains a significant problem for the treatment of many types of cancer. Fascin-1 (FSCN-1) is an actin-bundling protein involved in the invasion and metastasis of a variety of tumors. However, its involvement in drug resistance in hepatocellular carcinoma (HCC) remai...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Oncol
Main Authors: Zhang, Yuanbiao, Lu, Yi, Zhang, Chengwu, Huang, Dongsheng, Wu, Weiding, Zhang, Yuhua, Shen, Jian, Cai, Ying, Chen, Wei, Yao, Weifeng
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2018
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5873898/
https://ncbi.nlm.nih.gov/pubmed/29568938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2018.4327
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados